<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-036625</identifier>
<setSpec>0025-7753</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Infliximab and amyloidosis secondary to inflammatory bowel diseases. Reply</dc:title>
<dc:creator>Casellas, Francesc</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">No disponible</dc:description>
<dc:source>Med. clín (Ed. impr.);124(19): 758-758, mayo 2005.</dc:source>
<dc:identifier>ibc-036625</dc:identifier>
<dc:title xml:lang="es">Infliximab y amiloidosis renal secundaria a enfermedad inflamatoria intestinal. Réplica</dc:title>
<dc:subject>^d33150</dc:subject>
<dc:subject>^d29638</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d23695^s22057</dc:subject>
<dc:subject>^d699</dc:subject>
<dc:type>article</dc:type>
<dc:date>200505</dc:date>
</metadata>
</record>
</ibecs-document>
